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Abstract
Background: Acinetobacter baumannii is a multidrug-resistant bacterium responsible for nosocomial infections in
hospitals worldwide. Study of mutant phenotypes is fundamental for understanding gene function. The
methodologies developed to inactivate A. baumannii genes are complicated and time-consuming; sometimes
result in unstable mutants, and do not enable construction of double (or more) gene knockout mutant strains of
A. baumannii.
Results: We describe here a rapid and simple method of obtaining A. baumannii mutants by gene replacement via
double crossover recombination, by use of a PCR product that carries an antibiotic resistance cassette flanked by
regions homologous to the target locus. To demonstrate the reproducibility of the approach, we produced mutants
of three different chromosomal genes (omp33, oxyR, and soxR) by this method. In addition, we disrupted one of
these genes (omp33) by integration of a plasmid into the chromosome by single crossover recombination, the most
widely used method of obtaining A. baumannii mutants. Comparison of the different techniques revealed absolute
stability when the gene was replaced by a double recombination event, whereas up to 40% of the population
reverted to wild-type when the plasmid was disrupting the target gene after 10 passages in broth without selective
pressure. Moreover, we demonstrate that the combination of both gene disruption and gene replacement
techniques is an easy and useful procedure for obtaining double gene knockout mutants in A. baumannii.
Conclusions: This study provides a rapid and simple method of obtaining stable mutants of A. baumannii free of
foreign plasmidic DNA, which does not require cloning steps, and enables construction of multiple gene knockout
mutants.
Background
Acinetobacter baumannii is a Gram-negative coccobacil-
l u st h a ti si n c r e a s i n g l yr e c o g n i z e da sam a j o rp a t h o g e n
causing nosocomial infections worldwide, particularly in
patients admitted to intensive care units [1,2]. A. bau-
mannii can cause pneumonia, wound infections, urinary
tract infections, bacteremia and meningitis [3,4]. Its clin-
ical significance, especially in recent years, has increased
because of the ability of the bacterium to acquire resis-
tance determinants, making it one of the microorgan-
isms threatening the current antibiotic era [5].
The availability of the genome sequences of several
strains of A. baumannii opens up new perspectives in
the study of this bacterial species [6-9]. The artificial
introduction of mutations, by molecular techniques, is a
useful way of advancing our understanding of the genet-
ics of A. baumannii. The method most commonly used
to generate A. baumannii m u t a n t si n v o l v e si n t e g r a t i o n
o fap l a s m i di n t ot h ec h r o m o s o m eb ys i n g l ec r o s s o v e r
recombination. This method requires an internal frag-
ment homologous to the target gene cloned into a sui-
cide vector carrying resistance cassettes [10], which is a
major limitation for systematic construction of mutants
in post-genomic studies of A. baumannii. The possibility
that a second crossover event will return the mutant to
a wild-type phenotype is another important inconveni-
ence. The gene replacement method is a useful way of
overcoming these limitations.
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a non-replicating plasmid containing a deleted or modi-
fied gene, followed by low-frequency integration of a
plasmid into the chromosome and selection for resolu-
tion events to identify gene replacement candidates. In
fact, in A. baumannii, the plasmids pSSK10, pEX100T,
and pJQ200 are valuable tools for constructing mutants
by this methodology [11-13]. However, these gene repla-
cement methodologies require several subcloning steps
and phenotypic screenings. As a means of circumventing
these complicated approaches, we have developed a
rapid and simple method of inactivating of chromoso-
mal genes that does not require cloning steps. More-
over, the mutants grow directly on agar plates
containing appropriate antibiotics and are confirmed by
a simple PCR assay.
Integration of a linear piece of foreign DNA requires
two recombination events, whereby the original genetic
material is replaced by the recombinant DNA [14]. The
methodology used in the present study is based on elec-
troporation of a recipient A. baumannii strain with a
linear PCR fragment carrying an antibiotic resistance
cassette flanked by regions homologous to the target
locus. This method was used successfully to inactivate
three chromosomal loci in A. baumannii (omp33, oxyR,
and soxR). Moreover, the stability of the mutant, gene
expression, and the efficiency of gene disruption and
gene replacement methods were compared. Finally, the
combination of both techniques was found to be an easy
and useful method of obtaining double knockout
mutants of A. baumannii.
Results
Replacement of the A. baumannii omp33 gene
AP C Rp r o d u c tc o n t a i n i n gak a namycin resistance cas-
sette flanked by 500 bp of the regions surrounding the
omp33 gene (Figure 1a, Table 1) was introduced into
the A. baumannii ATCC 17978 strain by electropora-
tion. After selection on kanamycin-containing plates, the
A. baumannii Δomp33::Km mutant was obtained. The
frequency of generation of mutants by gene replacement
was approximately 10
-7. The PCR tests with locus-speci-
fic primers revealed that 2 of 15 clones obtained had
replaced the wild-type gene by the kanamycin cassette
(Figure 1b). In addition, allelic replacement in mutant
clones was further confirmed by sequencing the PCR
products obtained (data not shown).
Disruption of the A. baumannii omp33 gene
The gene disruption method was also used to inactivate
the omp33 gene. Gene disruption was carried out by
cloning a 387-pb internal fragment of the omp33 gene
into the pCR-BluntII-TOPO, to obtain the pTOPO33int
plasmid (Figure 2a). After transformation of the
recombinant plasmid into the A. baumannii ATCC
17978 strain and selection on kanamycin-containing
plates, the A. baumannii omp33::TOPO mutant was
obtained. The frequency of generation of mutants by
gene disruption was approximately 10
-5.P C Rt e s t sw i t h
locus-specific primers revealed that all the clones ana-
lyzed (10 of approximately 100) contained fragments of
the expected size (Figure 2b). In addition, gene disrup-
tion in mutant clones was further confirmed by sequen-
cing the PCR products obtained (data not shown).
Stable maintenance of plasmid insertion into the
chromosome requires drugselection
Gene knockout stability was tested by culturing both the
Δomp33::Km and omp33::TOPO A. baumannii mutants
under nonselective conditions (in the absence of antibio-
tics). Cultures of the mutant strains were initially grown
in LB and at passages 1, 5, and 10, the cultures were
dilution plated to obtain individual colonies, with repli-
cate platings of 100 colonies for each strain on LB and
LB supplemented with kanamycin. The frequency of
loss of kanamycin resistance in each passage after
growth in non-selective conditions was 1% (first), 9%
(fifth), and 37% (tenth) for the gene disrupted omp33::
TOPO mutant. By contrast, the gene-replaced Δomp33::
Km mutant was stable since no reversions were detected
in any passage. As expected, when the same experiment
was carried out in the presence of selective pressure,
both mutants remained stable (all colonies analyzed
were resistant to kanamycin).
Complementation
Taking advantage of the fact that the Omp33 protein
has been identified in the proteome of A. baumannii
ATCC 17978 strain by 2-DE and MALDITOF/TOF
[15], we observed the absence of the Omp33 protein by
2-DE analysis of the Δomp33::Km mutant (Figure 3a).
In order to complement the mutant phenotype, we con-
structed and tested the expression plasmid pET-RA.
The wild-type omp33 gene without its promoter region
was cloned into this expression plasmid. This construc-
tion was then introduced into the Δomp33::Km mutant
strain by electroporation. The cell surface-associated
proteins of the wild-type strain and the Δomp33::Km
mutant strain complemented with the pET-RA-OMP33
plasmid were extracted and analyzed by 2DE. The
Omp33 protein was detected in the mutant complemen-
ted with the Omp33 ORF under the control of the
b-lactamase CTX-M14 gene promoter of the pET-RA
plasmid (Figure 3a).
Omp33 detection
Western blot analysis was performed for further confir-
mation of the absence of Omp33 in the A. baumannii
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teins of wild-type strain, omp33 mutants, and pET-RA-
OMP33-complemented mutants were extracted and
subjected to Omp33 Western blot analysis (Figure 3b).
The Omp33 protein was not detected in the cell sur-
face-associated proteins of the mutants. As expected,
the Omp33 protein was detected in the cell surface-
associated proteins of both Δomp33::Km and omp33::
TOPO mutants containing the pET-RAOMP33 vector.
Reproducibility of the gene replacement method
To ensure reproducibility of the gene replacement
method, we produced the gene replacements of oxyR
and soxR (Table 1). The same gene replacement method
Figure 1 omp33 replacement. (a) Schematic representation of the linear DNA constructed for the omp33 gene replacement, which was
completely deleted. The oligonucleotides used (small arrows) are listed in Table 2. (b) Screening of omp33 A. baumannii mutants generated by
gene replacement. The numbers at the top are bacterial colony numbers. WT, Wild-type control with 2115 bp. Colonies 5 and 7 (lanes 5* and
7*) with 2214 bp (2115 bp - 834 bp [from omp33 deletion] + 933 bp [from kanamycin insertion]) were sequenced to confirm gene replacement.
Lambda DNA-Hind III and jX174 DNA-Hae III Mix (Finnzymes) was used as a size marker (M). The lengths of PCR products and of some
molecular size marker fragments are also indicated.
Table 1 Genes of A. baumannii strain ATCC 17978 inactivated in the present study
Product Name Gene location
a Length
b Locus tag
c Accession number
Outer membrane protein (Omp33) 3789880 to 3790566 228 A1S_3297 YP_001086288.1
Transcriptional regulator SoxR 1547914 to 1548219 101 A1S_1320 YP_001084350.1
Transcriptional regulator OxyR 1150365 to 1151153 262 A1S_0992 YP_001084026.1
aA. baumannii ATCC 17978 chromosomal coordinates for each gene.
bThe length is expressed as number of amino acids.
cBased on National Center for Biotechnology Information http://www.ncbi.nlm.nih.gov.
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to construct the ΔoxyR::Km and ΔsoxR::Km mutants
(Figure 4), with the primers listed in Table 2. The PCR
tests with locus-specific primers revealed that 2 of the 7
clones obtained for the oxyR gene, and all clones (3)
obtained for the soxR gene had replaced the wild-type
gene with the kanamycin resistance cassette (Figure 4).
In addition, allelic replacement in mutant clones was
further confirmed by sequencing the PCR products
obtained (data not shown). Transcriptional analyses
demonstrated the lack of both oxyR and soxR gene
expression in the ΔoxyR::Km and ΔsoxR::Km mutants,
respectively (Figure 5).
Construction of double knockout mutants
With the purpose of generating double knockout
mutants, the recombinant plasmid pTOPO33int was
transformed into both ΔoxyR::Km and ΔsoxR::Km
mutants. After selection on zeocin- and kanamycin-con-
taining plates, the ΔoxyR::Km-omp33::TOPO and
ΔsoxR::Km-omp33::TOPO A. baumannii double knock-
out mutants were obtained. PCR tests with locus-specific
primers revealed that both mutants had fragments of the
expected size (data not shown). In addition, gene disrup-
tion in mutant clones was further confirmed by sequen-
cing the PCR products obtained, by transcriptional
analyses to detect the oxyR and soxR genes (Figure 5),
and by Western blot analyses to detect the omp33 gene
(data not shown).
Discussion
Allelic mutation experiments enable investigation of the
functions of many unknown genes identified during the
sequencing of entire genomes. A number of methods
can be used to inactivate bacterial chromosomal genes.
As mentioned above, disruption of the A. baumannii
chromosome can be achieved by integration of a plas-
mid into the chromosome by single crossover recombi-
nation [10]. For this purpose, an internal fragment that
is homologous to the target gene must be cloned into a
non-replicating plasmid carrying at least one antibiotic
resistance cassette. However, the stability of this type of
mutant must be taken into account, because if the gene-
disrupted mutant cells are grown in a medium lacking
antibiotic pressure, the integrated sequence could be
removed, and the disrupted gene could revert to the
Figure 2 omp33 disruption. (a) Schematic representation of the strategy used to construct the omp33 mutant by gene disruption (omp33::
TOPO). The oligonucleotides used (small arrows) are listed in Table 2. The boxes indicated by A and A’ represent the original and the cloned
internal fragment of the omp33 gene, respectively. See Materials and Methods for details. (b) Screening of omp33 A. baumannii mutants
generated by gene disruption. The numbers at the top are bacterial colony numbers. All PCR products with 697 bp and 798 bp (amplified with
primer pairs 33extFW + SP6 and T7 + 33extRV, respectively) were sequenced to confirm omp33 gene disruption. Lambda DNA-Hind III and
jX174 DNA-Hae III Mix (Finnzymes) was used as a size marker (M). The wild-type strain (WT) was used as a negative control. The lengths of PCR
products and of some molecular size marker fragments are also indicated.
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found that this is indeed the case, as also found in simi-
lar studies with E. coli [16]. Therefore, one limitation of
the method is that the resulting mutants should always
be maintained in an appropriate medium containing
selective antibiotics. Another disadvantage of the
method is that further manipulations of the mutant
strain are restricted, because the same vector cannot be
used (because undesired recombination events would be
highly likely), thus making it impossible to construct
multiple gene knockout mutants.
The gene replacement method has recently been used
to generate stable A. baumannii mutants [11-13]. This
method is based on integration of a plasmid containing
the inactivated gene of interest into the bacterial chro-
mosome by single crossover recombination, followed by
resolution (or excision) of the integrated DNA by a sec-
ond recombination event, resulting in replacement of
the original wild-type gene by the inactivated gene. The
key step in this procedure, in A. baumannii, is counter-
selection (widely used with Gram-negative bacteria) by
the detection of sucrose sensitivity in the presence of
the Bacillus subtilis sacB gene coding for levansu-
crase [17]. This method of counter-selection has been
found to be useful for several other environmental bac-
teria [11,12,18]. Plasmids pSSK10, pEX100T, and
pJQ200 have been successfully used to obtain A. bau-
mannii mutants by this method [11-13]. However, most
bacteria subjected to homologous recombination, even
under negative selection for the sacB gene, are wild-type
and it is not possible to isolate the desired mutant
directly [19-21]. Another disadvantage of this method is
that integration of the DNA may not always provide the
desired replacement, since foreign DNA with low or no
sequence homology would rely on illegitimate recombi-
nation events, as previously reported for Acinetobacter
and other species [14,16]. In addition, all of these gene
replacement methodologies are time-consuming, and
require several steps involving subcloning into a suicide
delivery vector followed by electroporation into E. coli
and subsequent transfer into A. baumannii by electro-
poration or conjugation. To avoid such situations, we
propose a method based on the electroporation of A.
baumannii electrocompetent cells with linear DNA, a
PCR product including an antibiotic resistance cassette
flanked by regions homologous to the target locus.
However, as expected, we noted an important disadvan-
tage of the replacement method (which requires two
Figure 3 Omp33 detection. (a) 2-DE gels showing A. baumannii proteins from the wild-type strain (ATCC 17978), Δomp33::Km mutant, and
Δomp33::Km mutant complemented with pET-RA-OMP33 plasmid (+33). The black circles indicate the Omp33 protein. (b) Western blot analysis
showing the detection of the Omp33 protein in the protein extracts obtained from the wild-type and the pETRA-OMP33- complemented
mutant strains. (+33): Strains complemented with the pETRA-OMP33 plasmid. C-: Δomp33::Km mutant containing the pET-RA vector (without the
omp33 gene) as a negative control. The last lane (C+) indicates detection of the purified Omp33 protein used as a positive control. (c) Reversible
staining of the membrane containing the transferred protein extracts from the indicated strains showing similar amounts of the majority protein
(43 kDa) prior to Western blot analysis.
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tion method (which only requires one recombination
event), i.e. the low efficiency with regard to obtaining
mutants (10
-7 vs. 10
-5). In addition, we observed more
illegitimate recombination events with the new method
than with the gene disruption technique, since several
colonies acquired the resistance antibiotic cassette (con-
firmed by PCR), although the wild-type target gene was
not replaced (Figures 1, 2, and 4). Nevertheless, the new
method is a useful genetic tool for systematic generation
of knockouts. Moreover, to our knowledge, there are no
previous reports of double knockout mutant strains of
A. baumannii. However, we demonstrate that the com-
bination of both gene disruption and gene replacement
techniques is an easy and useful procedure for obtaining
double gene-knockout mutants in A. baumannii.
Taking into account the results presented here, it
intuitively appears that the gene replacement method
would be successful with any strain of A. baumannii,
including clinical strains, with the only limitation being
the use of an appropriate antibiotic resistance marker.
Although the kanamycin resistance cassette cannot be
used in clinical strains (all the clinical strains of A. bau-
mannii taken from our collection were kanamycin resis-
tant: data not shown), use of another antibiotic
resistance marker such as rifampicin (for which a low
level of resistance has been demonstrated in approxi-
mately 50% of multidrug-resistant A. baumannii clinical
isolates in Spain [22,23]), would be appropriate for gen-
erating mutants by gene replacement in these proble-
matic strains.
Conclusions
We report mutagenesis of three A. baumannii genes by
use of a simple and rapid method. The method offers
advantages such as no cloning steps, stability even in
the absence of selective pressure, and the possibility
of constructing multiple gene knockout mutants.
Figure 4 oxyR and soxR replacement. (a) Schematic representation of the linear DNA constructed for the oxyR gene replacement. The
oligonucleotides used (small arrows) are listed in Table 2. (b) Screening of oxyR A. baumannii mutants generated by gene replacement. The
numbers at the top are bacterial colony numbers. WT; Wild-type control showing 1600 bp. Colonies 4 and 7 (lanes 4* and 7*) showing 2275 bp
(1600 pb - 258 bp [from oxyR deletion] + 933 bp [from kanamycin insertion]) were sequenced to confirm gene replacement. Lambda DNA-Hind
III and jX174 DNA-Hae III Mix (Finnzymes) was used as a size marker (M). (c) Schematic representation of the linear DNA constructed for the
soxR gene replacement. The oligonucleotides used (small arrows) are listed in Table 2. (d) Screening of soxR A. baumannii mutants generated by
gene replacement. WT: Wild-type control with 1300 bp. Colonies 1, 2, and 3 (lanes 1*, 2*, and 3*) with 2093 bp (1300 bp - 140 bp [from soxR
deletion] + 933 bp [from kanamycin insertion]) were sequenced to confirm gene replacement. Lambda DNA-Hind III and jX174 DNA-Hae III Mix
(Finnzymes) was used as a size marker (M).
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of the genetics of A. baumannii. Although not tested, it
is also possible that this novel method may also work
with other pathogenic bacteria, in which genetic manip-
ulation techniques are generally less well established
than for E. coli and other bacterial species. Finally, the
gene disruption method is recommended when only one
A. baumannii gene must be inactivated, and when it is
possible to maintain selective pressure, since it is the
fastest and most efficient method of producing
A. baumannii mutants described so far.
Methods
Bacterial strains, plasmids, and growth conditions
Bacterial strains and plasmids used in this study are
listed in Table 3. The E. coli and A. baumannii strains
were grown in Luria Bertani (LB) medium [24]. When
necessary, kanamycin (50 μg/ml), rifampicin (50 μg/ml),
and zeocin (20 μg/ml for E. coli and 200 μg/ml for A.
baumannii) were added to the growth media. All cul-
tures were incubated at 37°C, 180 rpm. The frequency
of generation of mutants was calculated as the number
of mutants obtained, divided by the total CFU.
Table 2 Oligonucleotides used in the present study
Oligonucleotide name Sequence (5’ to 3’) Application
33intUP CTGGTGACGTTGCTGGTACA Construction of the omp33::TOPO mutant
33intDW CGTTACCGATGATACCGAAG Construction of the omp33::TOPO mutant
33extUP CCTTAACATTACGTTTCATC Confirmation of the omp33::TOPO mutant
33extDW CATGTAAGATGCACCAACTGC Confirmation of the omp33::TOPO mutant
Kmup CCGGAATTGCCAGCTGGG Kanamycin amplification
Kmdw TTCAGAAGAACTCGTCAAG Kanamycin amplification
33upFW GCTGAGCTCGTAAAGTCTGATG Construction and confirmation of the Δomp33::Km mutant
33upintRV CCCAGCTGGCAATTCCGGGGCTAATAATACAGCAGTGG Construction of the Δomp33::Km mutant
33dwintFW CTTGACGAGTTCTTCTGAAGGCTTAAATGCTAAATTCCG Construction of the Δomp33::Km mutant
33dwRV CGTTGCCTTTTACCGTAGTC Construction and confirmation of the Δomp33::Km mutant
33FWnest GCAATTGAATTGTGTGAC Construction of the Δomp33::Km mutant
33RVnest TGATAGCAATTCAAGAGG Construction of the Δomp33::Km mutant
OxyupFW AGTTAAAAAAAATTGAAGAAA Construction and confirmation of the ΔoxyR::Km mutant
OxyupintRV CCCAGCTGGCAATTCCGGTCACTTGATGATCTCGATTTA Construction of the ΔoxyR::Km mutant
OxydwintFW CTTGACGAGTTCTTCTGAATGAAGATCACCAGTTAATGG Construction of the ΔoxyR::Km mutant
OxydwRV TATATTAACCATATTGAAGCC Construction and confirmation of the ΔoxyR::Km mutant
OxyFWnest GCAACTTGATGCAGCGGT Construction of the ΔoxyR::Km mutant
OxyRVnest TCAACGTAGCTACTATCC Construction of the ΔoxyR::Km mutant
SoxupFW ATGAAAGAAAAAAACTATATA Construction and confirmation of the ΔsoxS::Km mutant
SoxupintRV CCCAGCTGGCAATTCCGGATATTTACTTAGGGCTTGTTT Construction of the ΔsoxS::Km mutant
SoxdwintFW CTTGACGAGTTCTTCTGAAGAACAATGTCCATT AGAAA Construction of the ΔsoxS::Km mutant
SoxdwRV TCTGACTTCGTTTTTTGCTTA Construction and confirmation of the ΔsoxS::Km mutant
SoxFWnest AATTGCACGTTGCGATAG Construction of the ΔsoxS::Km mutant
SoxRVnest TAAACCAGATAGCCCAAC Construction of the ΔsoxS::Km mutant
ATG33XbaI* ATCGTCTAGACCCAGCTTTATCTCTTGTTA Cloning of the omp33 gene
STOP33NcoI* ATCGCCATGGGGACTGGACTCAGGAAGATTTG Cloning of the omp33 gene
SoxRTup AGGAACTGTAATTGCACG RT-PCR for soxR detection
SoxRTrv CCAATCGAGAGATAGCTC RT-PCR for soxR detection
OxyRTup ATGGCTGCATTACCCTCACT RT-PCR for oxyR detection
OxyRTrv GCGCTCTACAATCTTCTCAC RT-PCR for oxyR detection
GyrBup ATGAGTTCAGAGTCTCAATCA RT-PCR for gyrB detection
GyrBrv CTGTTAAACCTTCACGCGCAT RT-PCR for gyrB detection
T7 AATACGACTCACTATAGGG Universal primer of the pCR-BluntII-TOPO plasmid
SP6 ATTTAGGTGACACTATAG Universal primer of the pCR-BluntII-TOPO plasmid
pETRAFW TTCTTCGTGAAATAGTGATGATTTTT Primer of the pET-RA plasmid
pETRARV CTGTTTCATATGATCTGGGTATC Primer of the pET-RA plasmid
*Oligonucleotides including the indicated restriction site (underlined).
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Genomic and plasmid isolation were performed with a
Wizard Genomic DNA Purification Kit (Promega) and
Wizard Plus SV Minipreps DNA Purification System
(Promega), respectively. Restriction enzymes and DNA-
modifying enzymes were purchased from Promega and
used according to the manufacturer’s recommendations.
Standard PCR amplifications were performed with Bio-
Taq DNA polymerase (Bioline). When necessary, high
fidelity and blunt-ended PCR products were amplified
with Expand High Fidelity (Roche) and Accuzyme (Bio-
line) DNA polymerases, respectively. All oligonucleo-
tides (Sigma) used in the study are listed in Table 2.
PCR products were purified with the High Pure
PCR Product Purification Kit (Roche). When high
concentrations of purified PCR products were required,
a MinElute PCR Purification Kit (Qiagen) was used. All
the recombinant plasmids obtained in the study, and the
PCR products indicated, were sequenced by the Macro-
gen sequencing service (Seoul, Korea).
Electroporation
All strains were made electrocompetent as follows. Bac-
terial overnight cultures were grown in LB broth and
subcultured at a dilution of 1:20 in 100 ml of fresh LB
medium. Cultures were grown at an OD600 of 0.8 and
then incubated on ice for 10 min. Cells were pelleted by
centrifugation and then washed 3 times with 10% (v/v)
glycerol and finally resuspended in 500 μl of 10% (v/v)
glycerol. An aliquot of 100 μl of the cell suspension was
Figure 5 Transcriptional analysis. RT-PCR analysis of RNA extracted from the wild-type, ΔoxyR::Km, ΔsoxR::Km, ΔoxyR::Km-omp33::TOPO, and
ΔsoxR::Km-omp33::TOPO strains showing the lack of oxyR and soxR transcription in the corresponding mutants. The gyrB gene was used as a
housekeeping gene. The lengths of cDNAs obtained are indicated.
Table 3 Bacterial strains and plasmids used in the present study
Strain or plasmid Relevant feature(s) Source or reference
Strains
Acinetobacter baumannii
ATCC 17978 Wild-type strain Laboratory stock
omp33::TOPO Derived from ATCC 17978. omp33 mutant obtained by plasmid insertion. Kan
R, Zeo
R Present study
Δomp33::Km Derived from ATCC 17978. omp33 mutant obtained by gene replacement. Kan
R Present study
ΔoxyR::Km Derived from ATCC 17978. oxyR mutant obtained by gene replacement. Kan
R Present study
ΔsoxR::Km Derived from ATCC 17978. soxR mutant obtained by gene replacement. Kan
R Present study
ΔoxyR::Km-omp33::TOPO Derived from ΔoxyR::Km. oxyR omp33 double mutant. Kan
R, Zeo
R Present study
ΔsoxR::Km-omp33::TOPO Derived from ΔsoxR::Km. soxR omp33 double mutant. Kan
R, Zeo
R Present study
Escherichia coli
TG1 supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5(rK- mK-) [F’ traD36 proAB lacIqZΔM15] Laboratory stock
Plasmids
pCR-BluntII-TOPO Suicide plasmid for A. baumannii. Kan
R, Zeo
R Invitrogen
pTOPO33int pCR-BluntII-TOPO containing a 387-pb internal fragment of the omp33 gene. Kan
R, Zeo
R Present study
pET-RA A. baumannii replication origin. CTX-M14 b-lactamase gene promoter. Rif
R Present study
pET-RA-OMP33 pET-RA containing the omp33 gene without its promoter region. Rif
R Present study
Kan, kanamycin; Zeo, zeocin; Rif, rifampicin.
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mixture was placed in a pre-chilled sterile electropora-
tion cuvette (1 mm electrode gap, Bio-Rad) and immedi-
a t e l yp u l s e db yu s eo faB i o - R a dG e n eP u l s e r( 1 . 8k V ,
200 W, and 25 μF). The mixture was incubated at 37°C
for 1 h with 1 ml of LB broth. Cells were spread on LB
agar containing the appropriate antibiotics and incu-
bated at 37°C.
Knockout construction by gene replacement
The upstream and downstream regions (approximately
0.5 kbp each) of the target gene were amplified from
genomic DNA of A. baumannii ATCC 17978 strain
using primer pairs upFW + upintRV and dwintFW +
dwRV (Figure 6), respectively. The kanamycin cassette
was amplified using primers Kmup and Kmdw (Table 2)
and the pCR-BluntII-TOPO vector (Invitrogen) as a tem-
plate. The upintRV and dwintFW primers (Figure 6) con-
tained, at their 5’ ends, an extension of approximately 20
nucleotides homologous to the Kmup and Kmdw pri-
mers, respectively. The three PCR products obtained in
the first step were mixed at equimolar concentrations
and subjected to a nested overlap-extension PCR with
F W n e s ta n dR V n e s tp r i m e r s( F i g u r e6 )t og e n e r a t ea
kanamycin resistance cassette flanked by both the
upstream and the downstream gene homologous regions.
The nested overlap-extension PCR was carried out with
an Expand High Fidelity Taq DNA polymerase (Roche),
according to the manufacturer’s recommendations; the
conditions used were as follows: 94°C for 15 s, 40°C for 1
min, 72°C for 2 min (10 cycles); 94°C for 15 s, 55°C for 1
min, 72°C for 3 min (20 cycles), and a final extension at
68°C for 10 min. Electroporation of the A. baumannii
ATCC 17978 strain was performed with approximately 5
μg of the purified PCR product containing the inactivated
gene. Cells were then plated on LB agar containing kana-
mycin for selection of mutants whose wild-type genes
were replaced by allelic exchange via double crossover
recombination. Gene replacement in candidate clones
was verified by PCR with upFW and dwRV primers (Fig-
ure 6). Allelic replacement in candidate clones was
further confirmed by sequencing the mutant region in
the resulting mutants.
Knockout construction by gene disruption
Plasmid insertion in the omp33 gene (Table 1) was car-
ried out as previously described [10], with slight modifi-
cations. Briefly, kanamycin- and zeocin-resistant plasmid
pCR-BluntII-TOPO, unable to replicate in A. bauman-
nii, was used as a suicide vector. An internal fragment
(387 bp) of the omp33 gene was amplified by PCR with
33intUP and 33intDW primers (Table 2) and genomic
DNA from A. baumannii ATCC 17978 as a template.
The PCR product was cloned into the pCR-BluntII-
TOPO vector and electroporated in E. coli to yield the
pTOPO33int plasmid (Table 3). Recombinant plasmid
(0.1 μg) was then introduced in the kanamycin- and
zeocin-susceptible A. baumannii ATCC 17978 strain by
electroporation. Mutants were selected on kanamycin-
containing plates. Inactivation of the omp33 gene by
insertion of the plasmid via single crossover recombina-
tion was confirmed by sequencing the amplified PCR
products with the SP6 + 33extUP and T7 + 33extDW
primer pairs (Table 2).
Construction of pET-RA plasmid for gene expression in A.
baumannii
In order to complement mutant phenotypes, the pET-
RA plasmid [Genbank: HM219006] was constructed,
and carried a rifampicin resistance cassette, a gene
Figure 6 Gene replacement. (a) Schematic representation of the strategy used to construct mutants by gene replacement. Small, red and
shaded arrows represent the primers, the target gene, and the kanamycin (Km) resistance cassette, respectively. The three PCR products
obtained (PCR1, PCR2, and PCR3) were mixed at equimolar concentrations and subjected to a nested overlap-extension PCR to generate the
desired linear DNA (see Materials and Methods for details). (b) Diagram showing the integration of the linear DNA via two recombination events.
(c) Representation of the original genetic material replaced by the recombinant DNA on the A. baumannii chromosome.
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Page 9 of 12coding for a green fluorescent protein (GFP), and the A.
baumannii replication origin, which is a plasmid origin
of replication (Figure 7). The pET-RA vector was used
to express promoterless genes under control of the
CTX-M14 b-lactamase gene promoter, previously cloned
upstream of the GFP gene (Figure 7). For pET-RA con-
struction, the pMW82 vector [Genbank: EF363313] was
amplified by PCR, excluding the coding region of the
ampicillin resistance cassette. The rifampicin resistance
cassette was then amplified from the pAT-RA vector
[Genbank: HM219005] and introduced into the pMW82
vector. The CTXM-14 promoter was cloned into the
pMW82 vector BamHIs i t e .T h eAcinetobacter replica-
tion origin was amplified from the pAT-RA vector and
cloned into the HindIII site of the pMW82 vector. As a
result, the pET-RA vector containing the CTXM-14
promoter was obtained and used for cloning and expres-
sion of genes in the XbaI-NcoI restriction sites.
Complementation of omp33 mutants
In order to complement the A. baumannii omp33
mutants, the omp33 ORF was amplified with the
ATG33XbaI and STOP33NcoI primers (Table 2) from
the A. baumannii ATCC 17978 strain genome and
cloned into the XbaI-NcoI restriction sites of the
pET-RA vector under the control of the b-lactamase
CXT-M-14 gene promoter yielding the pET-RA-OMP33
plasmid (Table 3). Acinetobacter baumannii omp33
mutants were transformed with the recombinant
pETRA-OMP33 plasmid. Transformants were selected
on rifampicin- and kanamycin-containing plates and
confirmed by PCR with the pETRAFW and pETRARV
primers (Table 2).
Mutant stability assays
The bacterial cultures were grown in 5 ml of LB broth
without kanamycin and incubated at 37°C. Every day,
during 10 consecutive days, 100 μlo fe a c hc u l t u r ew a s
diluted in 5 ml of fresh medium and incubated for 24
h. The same experiment was also carried out, for each
strain, with medium containing kanamycin. On days 1,
5, and 10, all cultures were diluted 10
6-fold and dilu-
tions (0.1 ml) were plated on non-selective plates. From
these plates, 100 colonies were each transferred to non-
Figure 7 pET-RA construction. Schematic representation of the construction of the pET-RA plasmid. The GenBank accession numbers of the
plasmids are indicated in parenthesis. Rif, rifampicin; Amp, ampicillin; GFP, green fluorescent protein.
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Page 10 of 12selective and selective plates to determine the frequency
of revertants, on the basis of the percentage of kanamycin-
susceptible colonies.
RNA methods
Bacterial cultures were grown overnight in LB broth
supplemented with the appropriate antibiotics at 37°C.
RNA isolation was performed with the RNAeasy Plant
Mini Kit (Qiagen). The total RNA extraction was sub-
jected to DNaseI (Invitrogen) treatment, following the
manufacturer’s instructions. In order to evaluate tran-
scription of the genes of interest, an RT-PCR was per-
formed with the First Strand cDNA Transcriptor
Synthesis Kit (Roche) and the gyrB as housekeeping
gene. Both the first strand synthesis and the PCR ampli-
fication were carried out with the specific primers listed
in Table 2. Finally, RT-PCR products were visualized in
a 1% agarose gel.
Protein analysis
Extraction of A. baumannii cell surface-associated pro-
teins and two-dimensional gel electrophoresis (2-DE)
were performed as described elsewhere [15]. Proteins
were quantified by the Bradford assay, as previously
described [25]. Forty μg of protein from each sample
was loaded onto a sodium dodecyl sulphate-polyacryla-
mide gel (12%) in a minigel apparatus (Bio-Rad) and
transferred to a Polyvinylidene Fluoride (PVDF) mem-
brane (Roche). To ensure transfer of proteins from the
gel, the membrane was stained with Ponceau red. The
membrane was then washed, blocked with 5% (wt/vol)
blocking agent (non-fat skimmed milk), and incubated
with a primary antibody against Omp33 obtained from
mouse (INIBIC, A Coruña). Proteins were visualized
by incubation with horseradish peroxidase-conjugated
secondary antibody, followed by enhanced chemilumi-
nescence ECL Plus (Amersham Pharmacia Biotech)
and detected with the LAS3000 chemiluminescence
detector (Fujifilm).
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